Evidence map›Paper›PMID 25970041›Full record

ArticleMolecules (Basel, Switzerland)2015

Effects of Two Different Rhodiola rosea Extracts on Primary Human Visceral Adipocytes.

Elena Pomari, Bruno Stefanon, Monica Colitti

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. Nutrients · 2019
    Trial
  2. Article
  3. Controlled Cultivation ConfersAntioxidants (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Stem cells international · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Elena PomariDepartment of Agricultural and Environmental Sciences, University of Udine, via delle Scienze, 206, 33100 Udine, Italy. elena.pomari@gmail.com.
Bruno StefanonDepartment of Agricultural and Environmental Sciences, University of Udine, via delle Scienze, 206, 33100 Udine, Italy. bruno.stefanon@uniud.it.
Monica ColittiDepartment of Agricultural and Environmental Sciences, University of Udine, via delle Scienze, 206, 33100 Udine, Italy. monica.colitti@uniud.it.
University of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhodiola rosea (Rro) has been reported to have various pharmacological properties, including anti-fatigue, anti-stress and anti-inflammatory activity. It is also known to improve glucose and lipid metabolism, but the effects of Rhodiola rosea on adipocyte differentiation and metabolism are not still elucidated. In this study the anti-adipogenic and lipolytic activity of two extracts of Rhodiola rosea, containing 3% salidroside (RS) or 1% salidroside and 3% rosavines (RR) on primary human visceral adipocytes was investigated. Pre-adipocytes were analyzed after 10 and 20 days of treatment during differentiation and after 7 days of treatment when they reached mature shape. The RS extract significantly induced higher apoptosis and lipolysis in comparison to control cells and to RR extract. In contrast, RR extract significantly reduced triglyceride incorporation during maturation. Differentiation of pre-adipocytes in the presence of RS and RR extracts showed a significant decrease in expression of genes involved in adipocyte function such as SLC2A4 and the adipogenic factor FGF2 and significant increase in expression of genes involved in inhibition of adipogenesis, such as GATA3, WNT3A, WNT10B. Furthermore RR extract, in contrast to RS, significantly down-regulates PPARG, the master regulator of adipogenesis and FABP4. These data support the lipolytic and anti-adipogenetic activity of two different commercial extracts of Rhodiola rosea in primary human visceral pre-adipocytes during differentiation.

Indexed as

AdipocytesAdipogenesisApoptosisCell DifferentiationCells, CulturedCell SurvivalDisaccharidesFatty Acid-Binding ProteinsFibroblast Growth Factor 2GATA3 Transcription FactorGene ExpressionGlucose Transporter Type 4GlucosidesGlycerolHumansIntra-Abdominal FatDisaccharidesFABP4 protein, humanFatty Acid-Binding ProteinsFibroblast Growth Factor 2GATA3 protein, humanGATA3 Transcription FactorGlucose Transporter Type 4GlucosidesGlycerolPhenolsPlant ExtractsPPAR gammaProto-Oncogene ProteinsrhodiolosiderosavinSLC2A4 protein, humanWNT10B protein, humanWnt3A ProteinWNT3A protein, humanWnt Proteinsdifferentiationgene expressionhuman visceral adipocytesRhodiola rosea

Identifiers

PMID25970041
PMCPMC6272273
OpenAlexW1595300334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.